Isotretinoin Generic denied as non-formulary by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for isotretinoin generic are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare May Deny Generic Isotretinoin as Non-Formulary — and Your Appeal Options

A non-formulary denial means generic isotretinoin is not included on your UnitedHealthcare plan's covered drug list, or is placed on a tier that results in it being deemed not covered under your benefit design. This can happen when a plan's formulary covers only a specific branded version (such as Absorica LD) and has not added the generic equivalent, or when the generic was recently approved and the formulary has not been updated.

Non-formulary denials are appealable on two grounds: (1) a formulary exception request based on medical necessity, and (2) a standard benefit appeal if you believe the denial was applied in error.

## The Federal Appeal Framework

• Formulary exception request: Most plans — including UHC — must have a process for requesting coverage of a non-formulary drug when a formulary alternative is not clinically appropriate for the specific patient. This is a prerequisite to or runs parallel to the formal appeal.
• Internal appeal (ERISA §503 / ACA §2719): After a formulary exception denial, you may file a formal internal appeal.
• External review: If the internal appeal is denied, external review is available, generally within approximately 4 months of the final internal denial notice. Non-formulary denials based on medical necessity are reviewable externally.

## Timeline

1. File a formulary exception request with supporting documentation from the prescriber. 2. If denied, file a formal internal appeal. 3. Escalate to external review if needed.

## Documentation to Gather

• Medical-necessity letter from the dermatologist explaining why generic isotretinoin (or the specific formulation prescribed) is required and why formulary alternatives, if any, are not clinically appropriate for this patient.
• Formulary alternatives review: Identify what isotretinoin products, if any, are on UHC's formulary for this plan. If the formulary covers a branded version but not the generic, the prescriber letter should address whether the branded formulation presents any patient-specific issue.
• iPLEDGE enrollment documentation confirming the patient is registered and the prescription is consistent with iPLEDGE requirements.
• Clinical notes supporting the diagnosis and need for isotretinoin therapy.
• Prior treatment history documenting what other acne treatments have been tried and failed.

## Criteria-Mapping Structure

For a formulary exception, the core question is: is there a clinically appropriate formulary alternative, and if so, why is it not suitable for this patient? Obtain UHC's formulary for this plan year and identify what is covered. Your appeal should directly address each reason the exception was denied. If cost is a factor, note that generic isotretinoin is typically significantly less costly than branded versions — framing coverage of the generic as the cost-conscious option can be effective in formulary exception arguments.